Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Payables (2021 - 2025)

Historic Payables for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to $817390.0.

  • HeartSciences' Payables fell 6908.1% to $817390.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $817390.0, marking a year-over-year decrease of 6908.1%. This contributed to the annual value of $2.9 million for FY2025, which is 20266.64% up from last year.
  • Latest data reveals that HeartSciences reported Payables of $817390.0 as of Q4 2025, which was down 6908.1% from $1.8 million recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Payables ranged from a high of $2.9 million in Q1 2025 and a low of $396506.0 during Q3 2024
  • For the 5-year period, HeartSciences' Payables averaged around $1.7 million, with its median value being $1.5 million (2023).
  • Examining YoY changes over the last 5 years, HeartSciences' Payables showed a top increase of 36010.53% in 2025 and a maximum decrease of 6908.1% in 2025.
  • HeartSciences' Payables (Quarter) stood at $2.5 million in 2021, then dropped by 22.99% to $1.9 million in 2022, then soared by 30.13% to $2.5 million in 2023, then grew by 5.52% to $2.6 million in 2024, then tumbled by 69.08% to $817390.0 in 2025.
  • Its Payables stands at $817390.0 for Q4 2025, versus $1.8 million for Q3 2025 and $2.9 million for Q2 2025.